BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34861399)

  • 1. Cohort Study and Bias Analysis of the Obesity Paradox Across Stages of Chronic Kidney Disease.
    Soohoo M; Streja E; Hsiung JT; Kovesdy CP; Kalantar-Zadeh K; Arah OA
    J Ren Nutr; 2022 Sep; 32(5):529-536. PubMed ID: 34861399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between Body Mass Index and Renal Outcomes Modified by Chronic Kidney Disease and Anemia: The Obesity Paradox for Renal Outcomes.
    Hung CC; Yu PH; Niu SW; Kuo IC; Lee JJ; Shen FC; Chang JM; Hwang SJ
    J Clin Med; 2022 May; 11(10):. PubMed ID: 35628912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body-mass index and risk of advanced chronic kidney disease: Prospective analyses from a primary care cohort of 1.4 million adults in England.
    Herrington WG; Smith M; Bankhead C; Matsushita K; Stevens S; Holt T; Hobbs FD; Coresh J; Woodward M
    PLoS One; 2017; 12(3):e0173515. PubMed ID: 28273171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality and Renal Outcomes Are Impacted by Obesity in Cardiorenal Metabolic Disease but Not in People with Concomitant Diabetes Mellitus.
    Al-Chalabi S; Chinnadurai R; Kalra PA; Sinha S
    Cardiorenal Med; 2024; 14(1):23-33. PubMed ID: 38160668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dual roles of obesity in chronic kidney disease: a review of the current literature.
    Rhee CM; Ahmadi SF; Kalantar-Zadeh K
    Curr Opin Nephrol Hypertens; 2016 May; 25(3):208-16. PubMed ID: 26999023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity and risk of end-stage renal disease in patients with chronic kidney disease: a cohort study.
    Lin TY; Liu JS; Hung SC
    Am J Clin Nutr; 2018 Nov; 108(5):1145-1153. PubMed ID: 30321257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of anthropometric measures with kidney disease progression and mortality: a retrospective cohort study of pre-dialysis chronic kidney disease patients referred to a specialist renal service.
    Davis E; Campbell K; Gobe G; Hawley C; Isbel N; Johnson DW
    BMC Nephrol; 2016 Jul; 17(1):74. PubMed ID: 27391644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BMI and its association with death and the initiation of renal replacement therapy (RRT) in a cohort of patients with chronic kidney disease (CKD).
    Wang Z; Zhang J; Chan S; Cameron A; Healy HG; Venuthurupalli SK; Tan KS; Hoy WE
    BMC Nephrol; 2019 Aug; 20(1):329. PubMed ID: 31438869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. U-Shaped Association between Waist-to-Hip Ratio and All-Cause Mortality in Stage 3-5 Chronic Kidney Disease Patients with Body Mass Index Paradox.
    Shen FC; Chiu YW; Kuo MC; Lin MY; Lee JJ; Hwang SJ; Chang JM; Hung CC; Chen HC
    J Pers Med; 2021 Dec; 11(12):. PubMed ID: 34945829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity paradox in patients with community-acquired pneumonia: Is inflammation the missing link?
    Braun N; Hoess C; Kutz A; Christ-Crain M; Thomann R; Henzen C; Zimmerli W; Mueller B; Schuetz P
    Nutrition; 2017 Jan; 33():304-310. PubMed ID: 27742103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body mass index modifies the risk of cardiovascular death in proteinuric chronic kidney disease.
    Obermayr RP; Temml C; Gutjahr G; Kainz A; Klauser-Braun R; Függer R; Oberbauer R
    Nephrol Dial Transplant; 2009 Aug; 24(8):2421-8. PubMed ID: 19244226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal association of body mass index and waist circumference with left ventricular mass in hypertensive predialysis chronic kidney disease patients.
    Stel VS; Ioannou K; Brück K; Dounousi E; Pappas K; Siamopoulos KC; Zoccali C; Jager KJ; Tsakiris D
    Nephrol Dial Transplant; 2013 Nov; 28 Suppl 4(Suppl 4):iv136-45. PubMed ID: 24049104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations Between Obesity and Kidney Disease in Chinese Men and Women With Type 2 Diabetes: A Retrospective Cohort Study.
    Xia Y; Jiang C; Lu J; Liu J; Gu T; Bi Y
    Can J Diabetes; 2022 Feb; 46(1):47-52.e3. PubMed ID: 34266745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity and the risk of cardiovascular and all-cause mortality in chronic kidney disease: a systematic review and meta-analysis.
    Ladhani M; Craig JC; Irving M; Clayton PA; Wong G
    Nephrol Dial Transplant; 2017 Mar; 32(3):439-449. PubMed ID: 27190330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body mass index, mortality, and gender difference in advanced chronic kidney disease.
    Huang JC; Lin HY; Lim LM; Chen SC; Chang JM; Hwang SJ; Tsai JC; Hung CC; Chen HC
    PLoS One; 2015; 10(5):e0126668. PubMed ID: 25942584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interventions for weight loss in people with chronic kidney disease who are overweight or obese.
    Conley MM; McFarlane CM; Johnson DW; Kelly JT; Campbell KL; MacLaughlin HL
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013119. PubMed ID: 33782940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The body mass index paradox and an obesity, inflammation, and atherosclerosis syndrome in chronic kidney disease.
    Beddhu S
    Semin Dial; 2004; 17(3):229-32. PubMed ID: 15144550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body Mass Index and Clinical and Health Status Outcomes in Chronic Coronary Disease and Advanced Kidney Disease in the ISCHEMIA-CKD Trial.
    Mathew RO; Kretov EI; Huang Z; Jones PG; Sidhu MS; O'Brien SM; Prokhorikhin AA; Rangaswami J; Newman J; Stone GW; Fleg JL; Spertus JA; Maron DJ; Hochman JS; Bangalore S;
    Am J Med; 2024 Feb; 137(2):163-171.e24. PubMed ID: 37925061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obstructive sleep apnea in non-dialyzed chronic kidney disease patients: Association with body adiposity and sarcopenia.
    Fernandes JFR; Barreto Silva MI; Loivos CP; Menna Barreto APM; Meira VDS; Kaiser SE; Bregman R; Klein MRST
    Nutrition; 2019 Jan; 57():282-289. PubMed ID: 30219685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anthropomorphic measurements that include central fat distribution are more closely related with key risk factors than BMI in CKD stage 3.
    Evans PD; McIntyre NJ; Fluck RJ; McIntyre CW; Taal MW
    PLoS One; 2012; 7(4):e34699. PubMed ID: 22511960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.